What this teaches
Halioua details exactly how she raised $5.1M pre-product for a dog-longevity biotech as a solo, first-time, female founder: building the narrative for a moonshot, sequencing investors, and handling deep-tech skepticism.
Why it matters
One of the best firsthand accounts from the underrepresented intersection of solo, female, and deep-tech/biotech founders.
Key lessons
- A bigger, weirder vision can be easier to fund than an incremental one
- Deep-tech seed rounds are sold on founder-market fit and de-risking milestones
- Solo founders can raise; the co-founder objection is answerable with execution
Building your investor list? Browse 1,000+ investor profiles on VCMatch and find the funds that actually match your stage and sector.